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Murine carcinoembryonic antigens serve as receptors for the binding and entry of the enveloped coronavirus mouse
hepatitis virus (MHV) into cells. Numerous receptor isoforms are now known, and each has extensive differences in its
amino terminal immunoglobulin-like domain (NTD) to which MHV binds via its protruding spike proteins. Some of these
receptor alterations may affect the ability to bind viral spikes. To identify individual residues controlling virus binding
differences, we have used plasmid and vaccinia virus vectors to express two forms of MHV receptor differing only in their
NTD. The two receptors, designated biliary glycoproteins (Bgp) 1a and 1bNTD , varied by 29 residues in the 107 amino acid
NTD. When expressed from cDNAs in receptor-negative HeLa cells, these two Bgp molecules were displayed on cell
surfaces to equivalent levels, as both were equally modified by a membrane-impermeant biotinylation reagent. Infectious
center assays revealed that the 1a isoform was 10 to 100 times more effective than 1bNTD in its ability to confer sensitivity
to MHV (strain A59) infection. Bgp1a was also more effective than Bgp1bNTD in comparative virus adsorption assays, binding
6 times more MHV (strain A59) and 2.5 times more MHV (strain JHMX). Bgp1a was similarly more effective in promoting
the capacity of viral spikes to mediate intercellular membrane fusion as judged by quantitation of syncytia following cocultiva-
tion of spike and receptor-bearing cells. To identify residues influencing these differences, we inserted varying numbers of
1b residues into the Bgp1a background via restriction fragment exchange and site-directed mutagenesis. Analysis of the
resulting chimeric receptors showed that residues 38 to 43 of the NTD were key determinants of the binding and fusion
differences between the two receptors. These residues map to an exposed loop (C-C* loop) in a structural model of the
closely related human carcinoembryonic antigen. q 1997 Academic Press
INTRODUCTION nized MHV strains (Barthold et al., 1986; Barthold, 1987).
These receptors are type I single-pass transmembrane
Coronaviruses are attractive objects for studies of ani- glycoproteins containing an ectodomain structure made
mal virus entry into cells because there exists a remark- up of four immunoglobulin-like domains (Dveksler et al.,
able level of variation in the ligands that engage virions 1991). The variability between 1a and 1b lies primarily in
with cells. Several strains of MHV are now recognized the most membrane-distal domain (Yokomori et al.,
(Siddell, 1995) and several receptors are also known 1992b, Dveksler et al., 1993a). This amino terminal do-
(Dveksler et al., 1991; Yokomori and Lai, 1992b; Nedellec main (NTD) is essential for virus binding in vitro (Dveksler
et al., 1994; Chen et al., 1995). This abundant natural et al., 1993b) and is similarly required to render cells
variation provides the opportunity to compare different susceptible to infection by MHV (Dveksler et al., 1995).
receptors for their ability to interact with different virus Initial studies on the coronavirus-binding functions of
strains. Such comparative analyses will allow one to Bgp1a and 1b indicated that they differ substantially in
identify the determinants responsible for differences in virion adsorptive capacity — when the two receptors
virus:cell interactions. were immobilized on nitrocellulose filters, only the 1a
In this study, we have focussed attention on two allelic isoform supported detectable virus-binding (Dveksler et
isoforms of the MHV receptor, biliary glycoprotein (Bgp) al., 1993a). This finding suggested that one or more of
isoforms 1a (Dveksler et al., 1991; Yokomori and Lai, the 29 amino acid differences between the 1a and 1b
1992a) and 1b (Yokomori and Lai, 1992b; Dveksler et al., NTDs (Yokomori and Lai, 1992b) are responsible for
1993a; McCuaig et al., 1993), and we have examined controlling virion adsorptive capacity, either because
their capacity to interact with purified enveloped coro- they provide direct receptor:virion contact points or be-
navirions. The 1a isoform is expressed in MHV suscepti- cause they control the overall conformation of the recep-
ble mice, while mouse strains homozygous for the 1b tors. If the NTD differences were indeed critical, then
isoform are generally resistant to many currently recog- identification of the relevant residues could be achieved
by constructing 1a /1b hybrid cDNAs and then measur-
ing virus binding to the protein products. We have used1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (708) 216-9574. E-mail: tgallag@luc.edu. this homologue scanning mutagenesis approach to pro-
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duce chimeras that have been useful in identifying resi- changed. 1b 84– 122 and 1b 70– 122 were made by ex-
change of AccI – PstI and BamHI– PstI fragments, respec-dues controlling the virus-adsorptive capacity of the
MHV receptor. tively (see Fig. 7). Additional exchanges were performed
after creation of a NdeI site at codon 53 using the mega-
primer mutagenesis procedure (Aiyar and Leis, 1993).MATERIALS AND METHODS
NdeI site creation altered codon 53 (N53H) in Bgp1a and
Cells and viruses codons 53 and 54 in Bgp1bNTD (N53H, K54M). 1b 54– 122
and 1b 10– 54 were made by exchange of NdeI –NdeIBaby hamster kidney (BHK), rabbit kidney (RK13), and
and NcoI – NdeI fragments, respectively (see Fig. 7). Re-human carcinoma (HeLa) cells were grown in Dulbecco
combinant 1b 38– 43 was made by oligonucleotide-di-modified Eagle medium (DMEM) supplemented with 10%
rected PCR mutagenesis using a primer spanning co-heat-inactivated fetal bovine serum (DFBS). Murine 17
dons 38– 43 and the NdeI site (Scharf, 1990). Nucleotidecl 1 cells (Sturman and Takemoto, 1972) were grown in
sequencing methods (Sanger et al., 1977) were employedDMEM containing 5% tryptose phosphate broth (TPB;
to confirm that Bgp1a and 1b clones matched those re-Difco Laboratories, Detroit, MI) and 5% DFBS. Murine
ported for these genes (McCuaig et al., 1993) and toastrocytoma (DBT) cells (Hirano et al., 1978) were grown
verify the isolation of all of the mutant receptors de-in minimal essential medium (MEM) containing 10% TPB
scribed herein.and 5% DFBS; these cells were used to measure MHV
infectivities by plaque assay. Murine coronavirus strains Generation of vaccinia virus recombinants.
A59 and JHMX (Makino et al., 1984) were grown in 17 cl
Recombinant viruses were prepared by infection of1 cells. Radiolabeled coronaviruses were collected from
RK13 cells with vaccinia virus strain WR (m.o.i.  0.05),culture supernatants after a 12 –16 hpi pulse with DMEM-
followed 1 hr later by lipofectin-mediated transfection1% dialyzed DFBS containing 100 mCi/ml Tran[35S] label
of the various pTM3-Bgp constructs (Felgner et al.,(ICN Radiochemicals, Irvine, CA). Clarified supernatants
1987). At 3 days postinfection, cultures were frozen atwere overlaid above 30% (w/w) sucrose cushions in PBS
0807. After three freeze – thaw cycles, debris was re-containing 0.01% BSA and subjected to ultracentrifuga-
moved by centrifugation and virus in the clarified mate-tion (Beckman– Spinco SW28 rotor for 3 hr at 28,000 rpm).
rial was plated on RK13 cells. Plaques arising from spe-Virion-containing pellets were resuspended in ice-cold
cific amplification of recombinant virus were revealedPBS containing 0.01% BSA and stored in silanized glass
by overlay of cells with mycophenolic acid-containingvials at 0807.
medium, as described by Falkner and Moss (1988). Vi-
rus from well isolated plaques was grown in RK13 cellsSynthesis and cloning of MHV receptor cDNA
to generate stocks of recombinant virus (vBgp1a,constructs
vBgp1D, vBgp1bNTD , vBgp1aQ10G,V123G , and additional 1a/1b
Methods for construction of vaccinia virus insertion/ chimeras).
expression plasmids (pTM3; Moss et al., 1990) encoding
MHV receptor isoform Bgp1a or Bgp1a lacking codons Immunoblot analysis of Bgp proteins
10– 122 (Bgp1D) have been described previously (Gal-
Cell monolayers were infected with the respectivelagher, 1996). These plasmid vectors were further modi-
vBgp recombinants (m.o.i.  10) and coinfected withfied by reinsertion of Bgp NTD sequences into Bgp1D.
vTF7.3 (m.o.i.  1). At 20 hr postinfection, lysis buffer (10To this end, the Bgp1a and 1b NTD sequences were
mM Tris – HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 0.5%amplified from outbred CD1 mouse liver RNA by RT-PCR
NP-40, 0.1 mM PMSF, and 0.3 U/ml aprotinin) was added,(Kawasaki, 1990) using primers based on the reported
and 10-ml aliquots (equivalent to 2 1 104 cells) wereBgp1a sequence (McCuaig et al., 1993) and products
subjected to Western immunoblotting. Receptor wasencoding for the 1a and 1b NTD were identified by
identified using antireceptor antibody 874 (a gift of Dr.restriction mapping and by sequencing (Sambrook et
M. J. Buchmeier, Scripps Research Institute, La Jolla, CA)al., 1989). 1b NTD sequences were cloned in-frame into
which was directed against conserved carboxy-terminalthe unique XmaI site of Bgp1D to generate the chimeric
residues 443– 458.Bgp1bNTD . Two undesired codon alterations that re-
sulted at the junctions of the insertion (Q10G and V123G)
Quantitation of relative Bgp cell surface levels
were introduced into a control Bgp1a construct by per-
forming a parallel insertion of the Bgp1a NTD into pTM3- At 20 hr postvaccinia infection, HeLa cells expressing
the Bgp molecules were washed three times with ice-Bgp1D. The control recombinant was designated as
Bgp1aQ10G,V123G . cold PBS and incubated for 1 hr at 47 with PBS containing
1 mg/ml NHS-LC biotin (sulfosuccinimidyl-6-(biotina-To construct additional Bgp chimeras for use in identi-
fying virus binding determinant(s), restriction fragments mido) hexanoate; Pierce Co., Rockford, IL). Unreacted
reagent was then quenched by the addition of 20 mMbetween pTM3-Bgp1a and pTM3-Bgp1bNTD were ex-
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Tris– HCl (pH 7.5) for 15 min at 47. Monolayers were Virus binding assays
washed thoroughly with PBS and lysed (2 1 106 cells/
HeLa cells overexpressing Bgp receptors from vac-
ml in lysis buffer). Clarified cytoplasmic extracts (250 ml)
cinia vectors were washed twice with ice-cold SFM at
were then mixed with antipeptide antibody 874 (12.5 ml)
20 hpi, then radiolabeled MHV particles were diluted in
and left overnight at 47. Twenty microliters of Gammabind
SFM and added at varying multiplicities. After incuba-
G-Sepharose (Pharmacia Biotech) was then added for 1
tions at 47, unadsorbed virions were removed and cellshr at 47. Sepharose beads were collected by centrifuga-
were rinsed five times with ice-cold PBS containing 0.5%tion, washed twice in RIPA buffer (10 mM Tris– HCl (pH
BSA and 0.05% Tween 20. RIPA buffer was added, and7.2) 150 mM NaCl, 1% sodium deoxycholate, 0.1% SDS,
radioactivities associated with the cell lysates and super-and 1% Triton X-100), then once in 10 mM Tris – HCl (pH
natant media were quantified by scintillation counting.7.2) containing 0.1% v/v Nonidet P-40. Immunoprecipi-
tated receptors were then subjected to Western blotting, Intercellular fusion assay
and the biotinylated fraction of each sample was identi-
The cell fusion-dependent reporter gene (b-galactosi-fied by incubation of blots for 1 hr with 0.1% v/v streptavi-
dase) activation assay of Nussbaum et al. (1994) wasdin– horseradish peroxidase (HRP) conjugate (Pierce
adapted for studies of MHV fusion as described pre-Co.) in PBS/3% BSA. Immobilized HRP was detected by
viously (Gallagher, 1996), with minor modifications. Inincubation in PBS containing 0.5 mg/ml 4-chloro-1-naph-
brief, stably transfected HeLa-Bgp1a cells were infectedthol, 17% v/v methanol, and 0.015% hydrogen peroxide.
with MHV-A59 (m.o.i.  10) and with vaccinia virus strainBlots were photographed (Polaroid 665 film) and signal
WR (m.o.i.  10). After 1 hr at 377, these cells were furtherintensities were quantified with an LKB ultrascan XL den-
transfected by lipofection with the reporter gene con-sitometer.
struct pG1NT7b-gal (kindly provided by Dr. Richard A.
Morgan, National Center for Human Genome Research,Indirect immunofluorescence
Bethesda, MD). Five hours later (before the onset of MHV
Vaccinia-infected BHK cells were challenged with A59-induced syncytium formation yet after pG1NT7b-gal
MHV-A59 (m.o.i.  10) at 10 hr postvaccinia infection. DNA amplification via vaccinia-encoded polymerases)
Fourteen hours later, cells were washed with PBS, fixed the cells were trypsinized, suspended in DMEM 10%
in acetone, and incubated for 1 hr at 227 with a 1:250 DFBS, and 0.6-ml (3 1 105 cell) aliquots were overlaid
dilution of antispike Mab 4B11.6 (Collins et al., 1982) on to confluent 5-cm2 monolayers of HeLa cells that were
in PBS/2% BSA. Bound Mab was detected with FITC- coinfected 20 hr earlier with vTF7.3 and vBgp recombi-
conjugated goat Ig directed against mouse Ig (Cappell, nants. After 3 hr at 377, the mixed monolayers were fixed
Durham, NC) and cells were photographed using a Leitz and stained with x-gal for in situ localization of b-gal
fluorescence microscope. activity (MacGregor et al., 1989). Alternatively, the mono-
layers were lysed by addition of 0.5% NP-40 in PBS and
Infectious center assays the quantity of b-galactosidase in each lysate was calcu-
lated using a colorimetric enzyme assay involving hydro-cDNA constructs encoding Bgp1a and Bgp1bNTD were
lysis of chlorophenyl red b-galactopyranoside (Nuss-inserted into plasmid expression vector pUHD-10-3
baum et al., 1994). OD 590 values were normalized by(Gossen and Bujard, 1992) and the plasmids (0.5 mg)
comparing the hydrolysis rates for each sample with thatwere transfected by lipofection into aliquots of 3 1 105
obtained for a standard preparation of E. coli b-galactosi-HeLa-tTA cells (Gossen and Bujard, 1992). To determine
dase (Calbiochem, La Jolla, CA) and were expressed astransfection efficiencies, parallel cultures were cotrans-
nanograms/well.fected with each pUHD-Bgp construct in conjunction with
0.05 mg of the b-galactosidase-encoding pCMV-b (Clon-
RESULTStech Labs, Inc.). In situ x-gal staining (MacGregor et al.,
1989) at 36 hr posttransfection revealed 11.8 and 12.5%
Synthesis of chimeric MHV receptors from vaccinia
b-gal-positive cells for the 1a and 1bNTD transfectants, re- virus vectors
spectively. To assess susceptibilities to MHV infection,
cells were washed at 36 hr posttransfection with cold A method for receptor overexpression on cell surfaces
was necessary to reproducibly measure the binding ofserum-free DMEM (SFM) and inoculated with MHV-A59
at 47 for 1 hr. Unbound virus was removed by washing MHV particles to a series of different receptors. HeLa
cell lines in which the MHV receptor gene was stably andwith PBS containing 0.5% BSA and 0.05% Tween 20 and
cells were then incubated in DMEM 10% DFBS for 2 hr constitutively expressed (HeLa-Bgp1a cells) have been
developed (Gallagher, 1996); however, we found thatat 377. Cells were then trypsinized, washed twice with
DMEM 10% DFBS, and serial dilutions were plated on clones varied dramatically in receptor levels (data not
shown). Therefore we anticipated difficulty in identifyingDBT indicator monolayers. Plaques were visualized after
a 2-day incubation period. a series of stable HeLa cell transfectants in which differ-
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FIG. 1. Schematic representation of MHV receptor mutants. D1 to D4 indicate the four immunoglobulin-like ectodomains, TM is transmembrane
region, C is cytoplasmic tail. Bgp1D lacks the NTD; replacement with NTD sequences from Bgp1b (Bgp1bNTD) and Bgp1a (Bgp1aQ10G,V123G) affected the
junction codons 10 and 123.
ent receptors are each present at the same levels. Thus The carboxy-terminal 16 amino acids are identical for
to increase the likelihood of equivalent receptor produc- all four receptors; and an antipeptide antibody (874)
tion, different receptor cDNAs were expressed from vac- raised against these cytoplasmic residues was available
cinia virus vectors. Such vectors have historically produced to us for use in monitoring receptor levels. Initial tests
high levels of surface glycoprotein (Broder et al., 1994; Nus- using this anti-C-terminal antibody were performed by
sbaum et al., 1995) and their preparation is known to be immunoblotting BHK and HeLa cell lysates collected 20
relatively straightforward (Falkner and Moss, 1988). hr after coinfection with vTF7.3 and vTM3-Bgp. The re-
A set of cDNAs capable of encoding four distinct sults (Fig. 2) revealed identical patterns of immunoreac-
forms of MHV receptor were each recombined into tive protein in lysates expected to contain Bgp1bNTD ,
the vaccinia virus genome using insertion vector pTM3 1aQ10G,V123G , and 1
a (lanes 1– 3, respectively). A sharp band
(Elroy-Stein and Moss, 1990; Moss et al., 1990) and at c. 55 kDa was detected, which likely represent under-
recombinant viruses (designated vTM3-Bgp) were se- glycosylated form(s) of the 424 amino acid proteins. The
lected as described under Materials and Methods. The series of bands ranging from 80 to 120 kDa indicated
use of the pTM3 vector places the cDNAs under the that equivalent levels of the various glycoforms of recep-
transcriptional control of a bacteriophage T7 promoter; tor were present in each infected culture. Lysates ex-
thus expression of MHV receptors required coinfection pected to contain Bgp1D had a similar, slightly more
of HeLa cells with vTM3-Bgp and vTF7.3, which en-
codes bacteriophage T7 RNA polymerase (Fuerst et
al., 1986).
The four translation products predicted from this ex-
pression scheme are depicted in Fig. 1. The mature
Bgp1a, after removal of its signal peptide, has an ectodo-
main composed of four immunoglobulin-like domains,
designated D1 to D4 (Dveksler et al., 1991). A deletion
mutant of Bgp1a (Bgp1D) was prepared by excision of
nucleotides encoding the bulk of the virus-binding D1
domain as well as 15 amino acids of the D2 domain.
Corresponding sequences from the allelic Bgp1b (McCu-
aig et al., 1993) were then placed back into the truncated
cDNA to generate a hybrid capable of encoding the chi-
FIG. 2. Immunoblot analysis of MHV receptors expressed from vac-
meric molecule Bgp1bNTD . These cloning manipulations cinia vectors. BHK cells were coinfected with vTF7.3 (m.o.i.  1) and
resulted in two unwanted codon changes (Q10G and with respective vTM3-Bgp vaccinia recombinants (m.o.i.  10). At 20
hr postinfection, cells were lysed and cytoplasmic extracts (equivalentV123G) at the exchange junctions (see arrows in Fig. 1).
to 105 cells per lane) were probed by Western immunoblotting withTo test the contribution that these two changes might
an antipeptide antibody directed against conserved carboxy-terminalhave on interaction with virions, cDNA for a Bgp1a con-
residues of Bgp. Lanes: (1) Bgp1bNTD, (2) Bgp1aQ10G,V123G , (3) Bgp1a, (4)taining the mutations (designated Bgp1aQ10G,V123G) was Bgp1D, (5) vTF7.3 alone, (6) molecular weight markers, kilodaltons.
prepared by ligating the NTD sequences of Bgp1a into Identical profiles of immunoreactive protein were observed in similarly
infected HeLa cell lysates.the deletion mutant.
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TABLE 1 sion vector pUHD-10-3 and transfected into HeLa-tTA
cells (Gossen and Bujard, 1992) by lipofection. After 36Relative Cell Surface Levels of Recombinant Receptors
hr, the cells were challenged with MHV-A59 at a range
Relative surface of input multiplicities, and the relative number of cells
Receptor recombinants a density b that became infected was assessed by infectious center
assays. The results (Fig. 4) revealed that some infectious
vBgp1a 1.0 centers (100.5 to 102 per 3 1 105 cells) were generatedvBgp1D 1.05
even by A59-challenged HeLa cells (hatched bars). ThisvBgp1bNTD 1.1
vBgp1aQ10G,V123G 0.95 was clearly due to a failure to quantitatively remove non-
vTF7.3 0 specifically adsorbed virions as numerous immunofluo-
rescence tests confirmed that HeLa-tTA cells could not
a Indicated vaccinia recombinants were used to express Bgp mole-
be infected by MHV A59 (data not shown). More impor-cules in HeLa cells.
tantly, the results of Fig. 4 showed that Bgp1a and 1bNTDb Portion of receptors present on cell surface were identified at
20 hr postinfection by a biotinylation process as described under Mate- differed significantly in their capacity to stimulate forma-
rials and Methods. Signals on nitrocellulose filters which represent tion of infectious centers. Infectious centers among
biotinylated receptors (50- to 110-kDa size range) were quantitated by Bgp1a transfectants (solid bars) were 3 to 4 log10 higherdensitometry. Values are normalized to those found in lysates from
than controls, while Bgp1b transfectants (open bars) werevBgp1a-infected cells.
only 1 to 2 log10 higher. Moreover, these differences in
receptor effectiveness could not be eliminated by in-
creasing input multiplicities during virus challenge. Fi-intense immunoreactive protein profile, with the apparent
nally, we observed a straightforward correlation betweenmolecular weights of the bands lower by approximately
infectious centers and virus yields; 24 hr after challenge20 kDa (lane 4).
of the Bgp transfectants with MHV A59 at 10 PFU perTo determine whether the four different MHV receptors
cell, yields were 69000, 3000, and 200 PFU/ml for the 1a,were displayed on the cell surface at similar levels, we
1bNTD , and control transfectants, respectively. Thus, whenfirst made the assumption that each receptor contains
expressed in the HeLa-tTA cells, Bgp1a was utilized assimilar numbers of exposed amines available for conju-
an MHV-A59 receptor much more effectively thangation with the membrane-impermeant biotinylation re-
Bgp1bNTD .agent sulfo-NHS-LC biotin. With this in mind, we deriva-
tized the proteins on intact cells at 20 hr postvaccinia
infection with the reagent and then we lysed cells and Virus binding capacities of the chimeric MHV
immunoprecipitated the receptor proteins. The relative receptors
proportion of biotinylated receptor among the immuno-
With the HeLa cell monolayers each expressing a dif-precipitates was then assessed by Western blotting us-
ferent MHV receptor on the cell surface, straightforwarding streptavidin-horseradish peroxidase as a detection
virus adsorption assays became feasible. Thus we col-reagent. By this method, the relative abundance of biotin-
lected particles from supernatants of MHV-infected 17cl1ylated receptors were similar in all cultures; densitomet-
cells that had been incubated for 4 hr in the presenceric scans of the blots revealed less than 10% variation
of trans[35S] label, and we concentrated the radiolabeledin signal intensities (Table 1), suggesting similar surface
virions by ultracentrifugation. Virion preparations werereceptor levels.
judged to be free of unincorporated radioactivity because
all [35S] was acid precipitable; additionally the virionsFunction of chimeric MHV receptors during infection
were deemed radiochemically pure as all electrophoreti-
cally separated [35S] proteins had mobilities consistentThe ability of the four receptors to support a productive
MHV infection was assessed by inoculation of the MHV with known MHV proteins (data not shown). In initial
experiments, aliquots of [35S]MHV-A59 were allowed tostrain A59 onto the vaccinia infected cell monolayers.
Fourteen hours later, MHV-A59 spike was visualized by bind to HeLa cells bearing different MHV receptors at 47
for varying time periods. Cells were then rinsed and theindirect immunofluorescence. All cells within cultures
shown to express the complete receptors contained percentage of added radioactivity remaining bound to
the monolayers was determined. The results (Fig. 5) re-spike antigen (Fig. 3, panels 1, 2, and 3) while the trun-
cated receptor failed to support MHV-A59 infection vealed a gradual increase in the levels of nonspecific
adsorption of virions to cells displaying Bgp1D, from 0.8%(panel 4), in concert with the results of Dveksler et al.
(1993b). after 15 min, to 1.6% by 1 hr, and 3.5% by 8 hr. MHV-A59
bound far more avidly to cells with Bgp1a or 1bNTD; 9.5Additional examination of the various receptors for
their ability to confer susceptibility to infection involved and 3%, respectively, after 1 hr. Subtraction of nonspecific
adsorption values revealed that the Bgp1bNTD was 6-foldinfectious center assays. To this end, cDNAs encoding
Bgp1a or Bgp1bNTD were introduced into plasmid expres- less effective than Bgp1a in virion adsorptive capacity.
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FIG. 3. Demonstration of MHV (strain A59) antigens in cells expressing full-length Bgp proteins. BHK cell monolayers grown on glass coverslips
were infected with vaccinia vectors to allow for cell surface expression of Bgps. 10 hr later, cells were inoculated with MHV A59. After a 14-hr
incubation period, cells were fixed in absolute acetone and A59 spike proteins were detected by immunofluorescence using anti-spike Mab 4B11.6
(Collins et al., 1982) and FITC-conjugated goat anti-mouse immunoglobulin. (1) Bgp1bNTD , (2) Bgp1aQ10G,V123G , (3) Bgp1a, (4) Bgp1D.
This difference in efficiency of binding was maintained identify the residues involved in virus binding by system-
atically exchanging 1a and 1b residues. This was accom-throughout the 8-hr, 47 incubation period. Moreover, this
plished through a series of restriction fragment ex-pattern whereby Bgp1a bound more virus than 1bNTD re-
changes to produce recombinant receptors containingmained constant over a 10-fold range of virus input multi-
varying numbers of 1b residues within a Bgp1a back-plicities (data not shown).
ground (Fig. 7). These receptors were expressed inIn all subsequent assays, we chose to interact [35S]
HeLa cells from vaccinia vectors and then tested forvirions with receptor-bearing cells for 1 hr at 47, as bind-
their ability to bind [35S] labeled MHV particles. Chimericing differences between the two receptor isoforms were
receptors containing 1b residues from positions 54 to 122readily discernable under these conditions. Our next
were as effective as 1a in binding, while the reciprocalassay involved testing the related strain JHMX for bind-
chimeras containing 1b residues 10 to 54 were ineffectiveing. For JHMX, a similar pattern of virus adsorption
(Table 2).emerged (Fig. 6). The amount of virion adsorption, how-
To further narrow down residues controlling receptorever, was lower for JHMX and the difference between
binding efficiency, we focused on codons 38 to 43, asBgp1a and Bgp1bNTD in JHMX adsorptive capacity was only
this region is the most variable among the presently se-2.5-fold, comparatively lower than the 6-fold difference
quenced Bgps (see Fig. 8; boxed region). Additionallyobserved when strain A59 was used.
this stretch of six residues is predicted to form a protrud-
ing loop connecting two b strands that form the frame-Mapping the MHV receptor determinants that control
work of the immunoglobulin-like CEA domain (Bates etvirus adsorption
al., 1992). Thus the Bgp1a residues 38 to 43 were
The two receptors contain a limited number of amino changed to 1b residues by oligonucleotide-directed muta-
acid differences and show measurable differences in genesis. The resulting chimera (1b 38– 43) exhibited a
weak binding efficiency that was equivalent to that ofvirus binding capacity. This provided an opportunity to
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FIG. 4. Quantitation of infectious centers following inoculation of
HeLa-Bgp transfectants with MHV (strain A59). Aliquots of 3 1 105
FIG. 5. Kinetics of virus binding to overexpressed Bgps. At 20 hr
HeLa cells were transfected with the indicated plasmids by lipofectin
postvaccinia infection, aliquots of 5 1 105 HeLa cells bearing the indi-
and then challenged 36 hr later with varying doses of MHV-A59 for 1
cated Bgp molecules were incubated at 47 for varying time periods
hr at 47. Inoculum virus was removed, and after a 2-hr penetration
with [35S]MHV-A59 (5 1 105 cpm/ml). After each time period, unad-
period at 377, cells were trypsinized and serial dilutions were plated
sorbed virions were removed and cells were washed extensively with
on DBT cell monolayers for development of infectious centers. P values
cold PBS containing 0.5% BSA and 0.05% Tween 20. Cells were then
relative to the Bgp1a values were obtained by Student’s t test. *, P 
lysed and the radioactivity associated with the lysates was calculated
0.01; **, P  0.001; ***, P  0.005.
as a percentage of total [35S] virus added. The error bars represent
standard deviations; average of two experiments.
Bgp1bNTD (Table 2). Thus a key determinant of binding
differences between the isoforms was present within enhance intercellular fusion with S-expressing cells. To
these six residues. do this, we employed a cell fusion-dependent reporter
gene activation assay (Nussbaum et al., 1994). In brief,
Correlation between virus binding capacity and
promotion of membrane fusion
In performing these experiments comparing the effi-
ciency of Bgp1a and Bgp1bNTD receptors, we readily identi-
fied a correlation between virus binding capacity and
syncytium formation. Upon infection by MHV-A59, stable
HeLa-Bgp1a transfectants fused rapidly into polykaryons,
while the corresponding HeLa-Bgp1bNTD cells were much
less susceptible. This was readily evident by simple mi-
croscopic examination of infected cell monolayers any-
where from 10 to 30 hr postinfection. However, previously
published information suggested that measurements of
additional receptor mutants for virus binding and fusion
promotion capacities might not reveal a direct relation-
ship between these two properties. First, evidence for
the uncoupling of virus binding and fusion activation
functions has been demonstrated in studies of mutant
retrovirus receptors (James et al., 1996; Lifson et al., 1988;
Truneh et al., 1991). Second, two reports focusing on the
FIG. 6. Quantitation of [35S]MHV binding to overexpressed Bgps.highly fusogenic MHV JHM strain have provided evi-
HeLa cells displaying the indicated Bgp molecules were incubated atdence that membrane fusion induced by this strain oc-
47 for 1 hr with [35S]MHV strains A59 or JHMX (both at 5 1 105 cpm/curs to a limited extent even in the absence of murine
ml). Radioactivities associated with the cells were then determined as
Bgp receptors (Gallagher et al., 1992; Nash and Buch- described in the legend to Fig. 5. The error bars represent standard
meier, 1996). Given these complex findings we wanted deviations; average of five experiments. Comparisons were made by
Student’s t test. *, P  0.005 versus Bgp1a; **, P  0.01 versus Bgp1a.to measure the relative abilities of our Bgp mutants to
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FIG. 7. Schematic representations of Bgp1a cDNA and chimeric receptors. Top line represents Bgp1a cDNA; thicker flanking lines represent
vector sequences. The indicated restriction enzymes were used to exchange cDNA fragments encoding Bgp1a residues with Bgp1b. b codons are
depicted by hatched boxes.
this assay involved infection of stable HeLa-Bgp1a The results obtained from a subset of these tests is
shown in Fig. 9. When cells were fixed and stained withtransfectants with vaccinia virus (strain WR) and MHV
strain A59 and then loading a fraction of the cells with x-gal (MacGregor et al., 1989), intense blue clusters were
abundantly evident in monolayers expressing Bgp1a (Fig.a transcriptionally silent b-galactosidase gene under the
control of the phage T7 promoter. These cells, which 9a, panel A) and the Bgp1aQ10G,V123G mutant. Fewer blue
syncytia were seen in the Bgp1bNTD-expressing mono-bear S proteins on their surface, were then overlaid at
subconfluent densities onto monolayers of HeLa cells layers (Fig. 9a, panel C), while blue cells were rare in
the cultures lacking the Bgp NTD altogether (Fig. 9a,coinfected with vTF7.3 and the respective vTM1-Bgp re-
combinants. Transfer of the T7 polymerase to the S-ex- panel B). Quantitation of the b-galactosidase activity in
detergent lysates prepared from each monolayer at vari-pressing cells causes b-galactosidase expression,
which can be measured and taken as an indicator of the ous times after cell mixing revealed the potency of each
receptor in promoting fusion (Fig. 9b). From 2 to 4 hr afteramount of fusion between receptor and spike-bearing
cells. cocultivation, specific b-galactosidase expression in cul-
tures harboring Bgp1a was 5– 6 times the level found in
Bgp1bNTD-containing cultures, in concert with the sixfoldTABLE 2
binding differences between these receptors. Quantita-
Relative Virus Binding and Cell Fusion Promoting Activities tive fusion assays were continued using cell monolayers
of Recombinant Receptors bearing the Bgp chimeras listed in Table 2. In every situa-
tion tested, the relationship between binding and fusionReceptor [35S] Virus Cell fusion
promotion was direct.recombinants a bound (%) b (ng of b-galactosidase/well)c
vBgp1a 10.4 (1.2) 12.9 DISCUSSION
(D 10– 122) 1.5 (0.5) 3.5
Studies of murine coronavirus entry into cells provide(1b NTD) 3.1 (0.3) 4.9
(1b 84 –122) 10.2 (1.1) 11.2 unique opportunities to probe structure– function rela-
(1b 70 –122) 9.8 (0.9) 11.4 tionships in both virion attachment proteins and their
(1b 54 –122) 9.4 (1.0) 11.5 cellular receptors. These viruses exhibit considerable
(1b 10 –54) 3.1 (0.2) 5.2
natural strain variation; a variation that is largely localized(1b 38 – 43) 2.9 (0.3) 5.9
to the spike (virion attachment) protein. Straightforward
a Indicated Bgp chimeras were expressed on HeLa cell surfaces correlations between spike sequences and biological
from vaccinia recombinants. functions such as membrane fusion allow for identifica-
b Percent [35S]MHV-A59 absorbed after a 1 hr, 47 incubation on vBgp- tion of relevant determinants (Bos et al., 1995; Gombold
infected HeLa cells (20 hpi). Standard deviations are in parentheses.
et al., 1993; Hingley et al., 1994). Because murine coro-c Intercellular fusion between receptor and spike-bearing cells was
navirus receptors exhibit genetic variation in the domainsdetermined after a 3 hr cocultivation period, as described in the legend
to Fig. 9. The data is an average of three independent experiments. known to interact with viral spikes (Dveksler et al., 1995),
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FIG. 8. Amino acid alignment of the N-terminal domain of murine biliary glycoproteins and human carcinoembryonic antigen. The large arrow at
position 107 marks the junction between the NTD and domain 2, while the numbers indicate endpoints of the various 1a/1b exchanges. The square
encloses the hypervariable region containing residues determining the efficiency of virus binding. Potential N-linked glycosylation sites are underlined.
Regions predicted to form the b strands (A– G) comprising the framework of the immunoglobulin-like NTD of human CEA are indicated as dashed
lines below the amino acid sequence (Bates et al., 1992).
an analogous set of experiments correlating receptor se- two receptors varied in 30 positions of the 112 residue
N-terminal region. When purified [35S] MHV strain A59quences with biological functions such as virion binding
capacity can reveal the molecular determinants of the was adsorbed to HeLa cells at 47 for 1 hr, 9% of added
radioactivity bound specifically to Bgp1a, while 1.4%virus:receptor interaction.
Previous qualitative assays in which virions were al- bound to Bgp1bNTD . When identical assays were per-
formed using [35S] MHV strain JHMX, 2.8% bound specifi-lowed to interact with denatured and immobilized MHV
receptors showed that allelic receptor isoforms termed cally to Bgp1a, while 0.8% bound Bgp1bNTD (Fig. 6). These
differences between the two receptors in virus bindingBgp1a and 1b do indeed differ in virion adsorptive capac-
ity (Boyle et al., 1987; Dveksler et al., 1993a), thereby capacity impact the outcome of MHV infection. We found
that transfection of either Bgp1a or Bgp1bNTD genes intoproviding the opportunity for determining which nonho-
mologous region(s) control the differences. Our initial HeLa cells conferred sensitivity to MHV A59 infection,
but Bgp1bNTD was inefficiently utilized as revealed bygoal was to establish assays in which we could accu-
rately measure the relative virus binding capacities of quantitation of infectious centers (Fig. 4). This latter find-
ing was generally consistent with a variety of previousthese two receptors. We anticipated that the success
of these assays might require abundant receptor levels observations. Chen and Baric (1996) reported that chal-
lenge of stable BHK-Bgp1a transfectants with MHV A59because previous attempts to measure virion binding to
murine cells endogenously expressing Bgps were not led to titers of 108 PFU/ml after 1 day, while parallel
challenge of BHK-mmCGM2 (Bgp1b) transfectantssensitive enough to reveal any specific adsorption (Yoko-
mori et al., 1993; Wilson and Dales, 1988). Our binding yielded only 104 PFU/ml. In similar tests, Compton (1994)
found analagous (but less dramatic) differences betweenassays therefore involved interaction of radiolabeled viri-
ons to native receptors that were overexpressed on the the two stably transfected BHK cell lines in their support
of MHV A59 infection. Finally, Yokomori and Lai (1992b)surface of HeLa cells from vaccinia vectors. By this
method, specific binding measurements were obtained, found that Cos7 cells transiently transfected with Bgp1a
or 1b supported very low levels of MHV A59; the 1aeven though the proportions of cell-associated [35S] viri-
ons were relatively low (Fig. 6). Adsorption might be lim- transfectants were marginally superior as virus hosts.
We have exchanged portions of Bgp1a cDNA withited in part by slow diffusion to cell monolayers, as pro-
longed incubation periods gradually increased binding those from Bgp1b and have assessed the resulting hybrid
gene products for virus binding capacity. Our most infor-(Fig. 5). Ligand densities also likely play a role— recom-
binant Bgp1a that is immobilized onto Sepharose at ex- mative recombinant receptor was a Bgp1a in which only
residues 38 – 43 were specific to 1b. This chimera wastraordinarily high densities will bind the majority of [35S]
virions in our recently developed in vitro receptor binding indistinguishable from the complete Bgp1bNTD in its sup-
port of virus binding (Table 2; see data highlighted byassays (Gallagher, 1997).
We established conditions in which parallel HeLa cell bold type), thus strongly suggesting that these six resi-
dues are the critical determinants controlling virus ad-monolayers displayed equivalent amounts of either
Bgp1a or a chimeric Bgp1bNTD on the cell surface. These sorption levels. Despite this compelling data, it must be
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FIG. 9. Quantitation of intercellular fusion between spike- and receptor-bearing HeLa cells. Stable HeLa-Bgp1a transfectants were infected with
MHV strain A59 (m.o.i.  2) and concomitantly transfected by lipofection with pG1NT7-bgal, which produces the b-gal product only in the presence
of T7 RNA polymerase. 5 hr later, the spike-bearing cells were trypsinized and overlaid onto HeLa cell monolayers that had been infected 20 hr
earlier with vTF7.3 and the indicated vTM3-Bgp recombinants. The resulting intercellular fusion levels were quantitated by measuring b-gal enzyme
activities produced by the mixing of T7 RNA polymerase (in vTF7.3/vTM3-Bgp cytosol) with pG1NT7-bgal (in MHV-A59 cytosol). (a) Cocultivated
cells were fixed after a 3-hr incubation and incubated with x-gal substrate to reveal the b-gal product in situ (A) Bgp1a, (B) Bgp1D, (C) Bgp1bNTD,
(D) Bgp1aQ10G,V123G . (b) At the indicated times after overlay, cell monolayers lysed with PBS containing 0.5% NP-40. b-gal activity in the lysates was
measured by a colorimetric assay and the OD590 nm values were normalized by comparison with OD590 nm produced by a preparation of purified b-
galactosidase.
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remembered that a tremendous number of possible re- the binding capacities of the receptors. In fact we have
come to similar conclusions using MHV JHM in place ofceptor chimeras can be generated, each with a unique
combination of 1a and 1b residues. It therefore remains A59— while receptor independent fusion was observed
with JHM, enhancement of this endogenous activity waspossible that investigations of additional 1a/1b combina-
tions will reveal a role for residues outside the 38– 43 most pronounced in the presence of receptors with 1a
residues 38 –43. At present we have no evidence of sepa-stretch in binding, perhaps because some patterns will
impact overall receptor conformation. rate domains on the Bgp molecule that are individually
responsible for binding and induction of membrane fu-Exchange of Bgp1a residues 38– 43 with those from 1b
also eliminates a potential N-linked glycan addition site sion. However, such separate domains may eventually
be identified, as studies of both the HIV and poliovirusat residue 37. However it has been established from
thorough mutagenesis studies in the Holmes laboratory receptors have revealed specific regions that induce
changes in virion conformation required for membranethat a carbohydrate at this position does not contribute
to virus binding (Dveksler et al., 1995). Identification of penetration (James et al., 1996; Morrison et al., 1994).
Finally, the results from these quantitative bindingthese critical amino acid residues led us to attempt
blockade of binding with synthetic peptides. To date we assays may shed light on the determinants of murine
coronavirus tropism in vivo. JHMX can infect murine brainhave been unable to interfere with the virus:receptor in-
teraction using synthetic Bgp1a peptide 33– 45, implying tissue more readily than A59 (Lavi et al., 1986; Robb and
Bond, 1979), and the overall abundance of Bgp1a and 1ba requirement for the immunoglobulin-like framework re-
gion in presenting a defined conformation of the resi- in brain is very low (Yokomori and Lai, 1992a, 1992b).
Given that JHMX is actually less avid than A59 in thedues.
According to a predicted three-dimensional model for Bgp binding properties, it appears likely that the different
in vivo tropisms of these strains are not dictated simplythe corresponding human CEA NTD (Bates et al., 1992),
residues 38 to 43 would represent a ‘‘loop’’ that is held by their capacity to bind these Bgps but rather by utiliza-
tion of alternative receptors or by additional events oc-in place by two of the beta strands (strands C and C*)
that comprise a portion of the framework region (Fig. 8). curring subsequent to binding.
This C-C* loop is further predicted to protrude from the
internal framework and thus it is reasonable to infer its ACKNOWLEDGMENTS
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